Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search


Employers Can Deny Coverage for Certain Infertility Treatments
October 07, 2003
An employer's medical plan that denies coverage for certain female-only infertility procedures does not violate either the Pregnancy Disability Act (PDA) or Title VII of the Civil Rights Act of 1964. The Second Circuit, in a ruling of first impression, concluded that neither are violated.
Property Condition Disclosure Act: The First Published Court Test
October 07, 2003
The Property Condition Disclosure Act (PCDA), which became effective on March 1, 2002, requires a seller of residential real property to deliver to a buyer a Property Condition Disclosure Statement (PCDS) before the buyer signs a binding contract. In <i>Malach v. Chuang, infra</i>, a Richmond County Civil Court judge construed ' for the first time ' the remedy provisions of the statute (R.P.L. sec. 465).
Real Property Law
October 07, 2003
Analysis of the latest cases of interest to your practice.
Landlord & Tenant
October 07, 2003
A rundown of the latest cases.
ONLINE: How to Research Human Organ Damage
October 07, 2003
If your product liability case involves damage to a specific organ, <i>eg,</i> heart damage allegedly caused by the use of fen-phen, professional organizations such as the American College of Cardiology (ACC) may offer some assistance. You can go to the association's Web site (www.acc.org) for information on a number of conditions.
CASE NOTES
October 07, 2003
Highlights of the latest intellectual property cases from around the country.
Daubert: 10 Years Later
October 07, 2003
<i>This is the first of a two-part article. Part two will appear next month.</i> Product liability practitioners must be intimately familiar with the strategy and tactics of challenging expert testimony under Rule 702, Fed. R. Evid., and the so-called <i>Daubert</i> trilogy of cases. Nearly 10 years ago, the United States Supreme Court, in <i>Daubert v. Merrill Dow Pharmaceuticals, Inc.</i>, 509 U.S. 579 (1993), vastly changed the road map for the admission of expert testimony. A body of case law has grown since that decision, providing numerous avenues to challenge admission of expert testimony. Because product liability cases usually rely on expert testimony, <i>Daubert</i> challenges are particularly important in them.
Development
October 07, 2003
The latest rulings you need to know.
Cooperatives & Condominiums
October 07, 2003
The latest rulings of importance to you and your practice.
Practice Tip: 30 Days Before Trial ' Must-Have Meetings
October 07, 2003
In the January 2003 Practice Tip, I discussed the list of 'issues, witnesses and exhibits' one should compile to highlight the evidence required to establish a <i>prima facie</i> product liability case. In this issue, I discuss two individuals with whom the trial lawyer should meet within the 30 days prior to trial: the client and the physician. In a future tip, I will discuss meeting with the engineering expert. For ease of reference, all individuals are deemed male. For purposes of the discussion, the case concerns injury caused by a defective machine.

MOST POPULAR STORIES

  • The FTC Gets Into the College Athlete NIL Game
    As national champions are crowned in men's and women's basketball, hundreds of thousands of college athletes are entering the influencer marketplace for the first time and now find themselves attractive candidates in the fast growing influencer marketing arena. With influencer marketing potentially providing a 5x return on investment, many brands are eager to get into the industry, but it doesn't come without risks as the FTC Commissioner is taking a closer look at the use of influencers for marketing.
    Read More ›
  • The Roadmap of Litigation Analytics
    Litigation analytics can be considered a roadmap of sorts — an important guide to ensure the legal professional arrives at the correct litigation strategy or business plan. However, like roadmaps, litigation analytics will only be useful if it's based on data that is complete and accurate.
    Read More ›